Lonza News 18. März 2025 Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma #Contract Pharma #Therapeutics Chooses
Lonza News 11. März 2025 Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News #Genetic Engineering #Therapeutics Taps
Lonza News 27. Feb. 2025 Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess International #Lonza facility #Vaxcyte cites
Lonza News 30. Jan. 2025 While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma #CDMO touts #Fierce Pharma
Lonza News 17. Jan. 2025 JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology #Lonza shares #Pharmaceutical Technology